[
    "{\"step_by_step_thinking\": \"To determine if Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis, we can look at the relevant documents. Document [1] titled 'Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis' provides information on a randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of the combination of eflornithine and sulindac in adults with familial adenomatous polyposis. The study found that the combination of eflornithine and sulindac did not significantly reduce the incidence of disease progression compared to either drug alone. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]